Bioprocess Insider

More Topics
Catalent limiting CAPEX as part of cost reduction plan
Global Markets
Catalent limiting CAPEX as part of cost reduction planCatalent limiting CAPEX as part of cost reduction plan

Only the most critical projects will be funded going forward as Catalent attempts to put out financial and operational fires.

byDan Stanton
May 22, 2023
|
1 Min Read
Krystal clear: FDA approves redosable gene therapy gel Vyjuvek
Regulations
Krystal clear: FDA approves redosable gene therapy gel VyjuvekKrystal clear: FDA approves redosable gene therapy gel Vyjuvek
byDan Stanton
May 22, 2023
1 Min Read
Thermo Fisher eyes up to $50bn M&A in coming years
Deal-Making
Thermo Fisher eyes up to $50bn M&A in coming yearsThermo Fisher eyes up to $50bn M&A in coming years
byDan Stanton
May 19, 2023
1 Min Read
uBriGene steps into US with Mustang Bio facility buy
Deal-Making
uBriGene steps into US with Mustang Bio facility buyuBriGene steps into US with Mustang Bio facility buy
byMillie Nelson
May 19, 2023
1 Min Read
Two-pronged approach advances Omisirge accessibility, says Gamida
Regulations
Two-pronged approach advances Omisirge accessibility, says GamidaTwo-pronged approach advances Omisirge accessibility, says Gamida
byMillie Nelson
May 18, 2023
1 Min Read
Scribe and Prevail ink $75m CRISPR deal
Deal-Making
Scribe and Prevail ink $75m CRISPR dealScribe and Prevail ink $75m CRISPR deal
byMillie Nelson
May 18, 2023
1 Min Read
Astellas and Sony ink deal to develop ADC platform
Deal-Making
Astellas and Sony ink deal to develop ADC platform
Astellas and Sony ink deal to develop ADC platform
May 17, 2023
|
1 Min Read
byMillie Nelson
Bavarian Nordic: Boosting inhouse manufacturing drives vaccine ambition
Facilities & Capacity
Bavarian Nordic: Boosting inhouse manufacturing drives vaccine ambition
Bavarian Nordic: Boosting inhouse manufacturing drives vaccine ambition
May 17, 2023
|
1 Min Read
byDan Stanton
Lilly working to resolve mirikizumab manufacturing issues following CRL
Regulations
Lilly working to resolve mirikizumab manufacturing issues following CRL
Lilly working to resolve mirikizumab manufacturing issues following CRL
May 17, 2023
|
1 Min Read
byDan Stanton
NewBiologix launches with $50m to develop CGT platform
Therapeutic Class
NewBiologix launches with $50m to develop CGT platform
NewBiologix launches with $50m to develop CGT platform
May 16, 2023
|
1 Min Read
byMillie Nelson
BPI Europe: Dutch industry board pushes country’s CGT prowess
Global Markets
BPI Europe: Dutch industry board pushes country’s CGT prowess
BPI Europe: Dutch industry board pushes country’s CGT prowess
May 16, 2023
|
1 Min Read
byMillie Nelson
Fujifilm FY22: CDMO biz robust but COVID demand runs its course
Facilities & Capacity
Fujifilm FY22: CDMO biz robust but COVID demand runs its course
Fujifilm FY22: CDMO biz robust but COVID demand runs its course
May 15, 2023
|
1 Min Read
byDan Stanton
Cali clinical plant to make ‘ImmPACT’ on CAR-Ts
Facilities & Capacity
Cali clinical plant to make ‘ImmPACT’ on CAR-Ts
Cali clinical plant to make ‘ImmPACT’ on CAR-Ts
May 15, 2023
|
1 Min Read
byDan Stanton
WHO-backed mRNA tech transfer platform looks beyond COVID, says MPP
Global Markets
WHO-backed mRNA tech transfer platform looks beyond COVID, says MPP
WHO-backed mRNA tech transfer platform looks beyond COVID, says MPP
May 15, 2023
|
1 Min Read
byAnna Brown
Recipharm biologics biz signs mRNA deal with MIT
Deal-Making
Recipharm biologics biz signs mRNA deal with MIT
Recipharm biologics biz signs mRNA deal with MIT
May 15, 2023
|
1 Min Read
byMillie Nelson
In on the ACT: Eppendorf adds sustainability accreditation
Upstream & Downstream Processing
In on the ACT: Eppendorf adds sustainability accreditation
In on the ACT: Eppendorf adds sustainability accreditation
May 12, 2023
|
1 Min Read
byDan Stanton
Waters hopes for bioanalytic windfall after $1.36bn deal bring light scattering
Deal-Making
Waters hopes for bioanalytic windfall after $1.36bn deal bring light scattering
Waters hopes for bioanalytic windfall after $1.36bn deal bring light scattering
May 12, 2023
|
1 Min Read
byDan Stanton
Expert: Synthetic promoters for transcription the ‘foundation of modern biotech'
Upstream & Downstream Processing
Expert: Synthetic promoters for transcription the ‘foundation of modern biotech'
Expert: Synthetic promoters for transcription the ‘foundation of modern biotech'
May 12, 2023
|
1 Min Read
byAnna Brown
Yposkesi launches LentiSure™, LV vector production platform optimized for higher yields
Sponsored Content
Yposkesi launches LentiSure™, LV vector production platform optimized for higher yields
Yposkesi launches LentiSure™, LV vector production platform optimized for higher yields
May 11, 2023
|
1 Min Read
byBPI Staff
Bioprocess transformation: It's not just about the tech, says expert
Facilities & Capacity
Bioprocess transformation: It's not just about the tech, says expert
Bioprocess transformation: It's not just about the tech, says expert
May 11, 2023
|
1 Min Read
byMillie Nelson
Trial regs a challenge for vaccine developers, study
Regulations
Trial regs a challenge for vaccine developers, study
Trial regs a challenge for vaccine developers, study
May 10, 2023
|
1 Min Read
byGareth Macdonald
Sandoz signs biosimilar pact with Just-Evotec
Deal-Making
Sandoz signs biosimilar pact with Just-Evotec
Sandoz signs biosimilar pact with Just-Evotec
May 10, 2023
|
1 Min Read
byDan Stanton
Ascend launches with $130m to tackle manufacturability of AAVs
Therapeutic Class
Ascend launches with $130m to tackle manufacturability of AAVs
Ascend launches with $130m to tackle manufacturability of AAVs
May 10, 2023
|
1 Min Read
byDan Stanton
Voices of Biotech: Bristol Myers talks diverse leadership
BPI Podcasts
Voices of Biotech: Bristol Myers talks diverse leadership
Voices of Biotech: Bristol Myers talks diverse leadership
May 10, 2023
byLottie Leinfellner
Baxter sells biopharma services business to PE for $4.25bn
Deal-Making
Baxter sells biopharma services business to PE for $4.25bn
Baxter sells biopharma services business to PE for $4.25bn
May 9, 2023
|
1 Min Read
byDan Stanton
ZETA magnetic mixers cause a stir at Interphex
Webcasts
ZETA magnetic mixers cause a stir at Interphex
ZETA magnetic mixers cause a stir at Interphex
May 8, 2023
|
20 Min View
byDan Stanton
Ginkgo and Boehringer partner to develop therapeutic molecules
Deal-Making
Ginkgo and Boehringer partner to develop therapeutic molecules
Ginkgo and Boehringer partner to develop therapeutic molecules
May 8, 2023
|
1 Min Read
byMillie Nelson
GSK ready to meet RSV vaccine demand after Arexvy approval
Regulations
GSK ready to meet RSV vaccine demand after Arexvy approval
GSK ready to meet RSV vaccine demand after Arexvy approval
May 8, 2023
|
1 Min Read
byDan Stanton
Merck KGaA to build Asia-Pacific bioprocessing center
Facilities & Capacity
Merck KGaA to build Asia-Pacific bioprocessing center
Merck KGaA to build Asia-Pacific bioprocessing center
May 8, 2023
|
1 Min Read
byMillie Nelson
FDA hits both Lilly and Rentschler with 483s
Regulations
FDA hits both Lilly and Rentschler with 483s
FDA hits both Lilly and Rentschler with 483s
May 5, 2023
|
1 Min Read
byDan Stanton
Dutch gov puts vaccine maker Intravacc up for sale
Global Markets
Dutch gov puts vaccine maker Intravacc up for sale
Dutch gov puts vaccine maker Intravacc up for sale
May 4, 2023
|
1 Min Read
byDan Stanton
J&J forks out $245m to develop CAR-T therapies
Deal-Making
J&J forks out $245m to develop CAR-T therapies
J&J forks out $245m to develop CAR-T therapies
May 4, 2023
|
1 Min Read
byMillie Nelson
BioCina awarded $3.3m grant to bolster mRNA capabilities
Deal-Making
BioCina awarded $3.3m grant to bolster mRNA capabilities
BioCina awarded $3.3m grant to bolster mRNA capabilities
May 4, 2023
|
1 Min Read
byMillie Nelson
Making sensor at Interphex: Hamilton showcases process analytics tech
Webcasts
Making sensor at Interphex: Hamilton showcases process analytics tech
Making sensor at Interphex: Hamilton showcases process analytics tech
May 3, 2023
|
20 Min View
byDan Stanton
Astellas forks out $5.9bn to buy Iveric Bio
Deal-Making
Astellas forks out $5.9bn to buy Iveric Bio
Astellas forks out $5.9bn to buy Iveric Bio
May 3, 2023
|
1 Min Read
byMillie Nelson

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024